CHAPTER 6
DEVELOPMENT OF FAST DISSOLVING TABLETS OF AMLODIPINE BESYLATE 6.1 Standard graph of Amlodipine besylate 100 mg of amlodipine besylate was weighed accurately and transferred to the 100 ml volumetric flask and minimum quantity of ethanol was added to solubilize the drug. The volume is made up to 100 ml with ethanol to give the stock solution. The stock solution was suitably diluted with phosphate buffer of pH 6.8 to give the concentrations of 5,10,15,20 and 25 µg/ml and the absorbance was measured at 239 nm.
Method to prepare solid dispersions
In solvent evaporation method, solvents which were selected are dichloromethane and ethanol. Five different ratios of drug and carrier were utilized.
The employed ratios were 1:1, 1:2, 1:3, 1:4, 1:5 for the formulation of solid dispersions of amlodipine besylate. The subsequent amount of amlodipine besylate and carrier was dissolved in the required volume of dichloromethane and ethanol taken in a conical flask. After getting a completely dissolved clear polymeric solution, solvent was evaporated by vacuum evaporator at 40°C and the dispersion acquired was further dried in a desiccator. The dried dispersions were then pulverized and which was then sifted through sieve no 60.
[56] 
Drug content uniformity of SDs
The SDs equivalent to 10mg of amlodipine besylate was taken from each batch, and it was then analyzed for uniformity of drug content. In a 100ml volumetric flask, an accurately weighed quantity of amlodipine besylate SDs was taken and dissolved with a little amount of ethanol. The stock solutions which were prepared are then filtered and diluted suitably. The amount of drug present in SDs was analyzed using a Shimadzu UV-visible spectrophotometer at 239 nm.
[57]
Infrared Spectral analysis
The Fourier Transform-IR spectra of the amlodipine besylate and the solid dispersions were obtained using a PerkinElmer-FT-IR 8201 PC spectrophotometer. It was performed with the help of the KBr disc method, and the value was in the range of 4000 to 400 cm -1 . This was conducted to study the compatibility of drug and polymers used in the preparation studies.
[58]
XRD Studies
The powdered X-ray diffraction specimens were recorded using XpertPro analytical diffractometer with Cu as an anode material. A 2θangle range of 0°-100° was used for the sample analysis.
DSC Studies
The DSC studies of the pure amlodipine besylate, carriers and solid dispersions were performed with the help of a DSC-60 (Shimadzu Corporation Japan) instrument with an intra-cooler. The DSC temperature was calibrated using standard, and the nitrogen gas was introduced to maintain an inert atmosphere [59]
SEM Studies
SEM was utilized for the investigation of the surface morphology of amlodipine besylate, Poloxamer 407, Poloxamer 188 and SDs. To mount, a doublefaced adhesive tape was used and then thin gold palladium layers was used for sputtering.
Dissolution studies
According to the method in USP XXIV the dissolution studies were performed. It was conducted using Apparatus II, and the paddles are rotated at 50 rpm with 900ml of phosphate buffer pH 6.8 at 37˚C. The dissolution study was conducted using solid dispersions equivalent to 10 mg of amlodipine besylate. 5ml of sample were taken at selected time intervals (10, 20, 30, 40, 60 and 90 min), and the aliquots withdrawn were substituted with the fresh buffer which was pre-warmed to 37˚C each time. Measurement of absorbance was performed by UV spectroscopy at 239 nm.
[60]
Preparation of fast dissolving tablets of amlodipine besylate
The SD formulation which showed highest drug release was formulated into tablets using various proportions of superdisintegrants. The SDs equivalent to 10 mg of amlodipine besylate was used to prepare FDT, and the formulation of tablets is given in the USP test if not more than two tablets are outside the limit and no tablet differs by more than twice the limit.
Tablet friability
Roche friabilator was used to perform the friability test. Twenty tablets were selected and subjected to 100 revolutions. The speed was adjusted to 25 rotations per min and rotated for 4 min. The tablets were wiped with a clean cloth and weighed again. The friability was calculated as the percentage loss which should not exceed 1%.
[62]
Drug content
The drug content was analyzed by selecting ten tablets and each tablet is undergone for determination of drug content. The tablets complies the test if the content of each of at least nine tablets were in the range of 85-115% of the labeled amount of the drug. The tenth tablet should not contain <75% or >125% of the labeled content. If these conditions were not met the remaining 20 tablets must be analyzed individually and all they should be within the limit.
[63]
In-vitro drug release study
The release rate of amlodipine besylate from fast dissolving tablets was determined using USP XXIV dissolution testing apparatus II. The in-vitro dissolution test was performed using 900 ml of phosphate buffer pH 6.8 at (37±0.5˚C) 50rpm.
Aliquot of dissolution medium was withdrawn at regular time intervals, and the same volume of pre-warmed fresh dissolution medium was replaced. The samples were filtered, and the amount of drug released was determined by Shimadzu-UV spectrophotometer at 239 nm.
